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Introduction
Two guiding principles of mental health policy are that 
patients should exercise self-determination with respect 
to their treatment,1,2 and that they should receive the least 
restrictive form of care. In England, the Care Programme 
Approach (CPA)3 provides a framework for integrated 
mental health care. It is directed at the most vulnerable 
mental health service users and requires: the systematic 
assessment of health and social needs; the formation of a 
care plan; the appointment of a key worker or care 
coordinator to monitor and coordinate care; and regular 
review and amendments to care plans where necessary. 
As part of the CPA process patients now routinely 
participate in care planning, yet the number of patients 
admitted on a compulsory basis to psychiatric hospitals 
in England and Wales per head of population increased 
by over 50% in the decade to 1995, and then rose by 13%, 
from 26 632 to 30 092, during the decade to 2010–11.4 
Rates of involuntary hospitalisation are diﬃ  cult to 
compare internationally, but in countries with reliable 
data, per person rates are also increasing.5 Most patients 
ﬁ nd involuntary treatment a negative experience, and 
have described it as unjustiﬁ ed even a year later.6–8
A Joint Crisis Plan (JCP) aims to empower patients 
while facilitating early detection and treatment of 
relapse.9,10 The JCP format was developed after widespread 
consultation with patient groups.10 It is formulated by the 
patient in collaboration with staﬀ . Held by the patient, it 
contains his or her treatment preferences for any future 
psychiatric emergency, when he or she may be too unwell 
to express clear views. The assumption is that such active 
involvement by the patient in the process of crisis 
planning will increase the likelihood of averting major 
relapse and the need for compulsory detention.
Two studies have suggested that JCPs might reduce 
compulsory treatment and improve therapeutic relation-
ships. A pilot study of JCPs done in south London9 
showed that at 6–12 month follow-up, most participants 
with JCPs reported feeling more involved in their care, 
were positive about their situation, and felt more in 
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control of their mental health. An exploratory ran-
domised study of JCPs11 found that use of the Mental 
Health Act (MHA) was signiﬁ cantly reduced for the 
intervention group, the ﬁ rst clinical intervention to do so 
in mental health services. A health economic analysis of 
this trial found that the intervention had a high 
probability of being cost eﬀ ective.12
In this paper we report the clinical outcomes of a 
deﬁ nitive trial of JCPs.13 An economic evaluation of the 
trial is in submission. The primary hypothesis tested was 
that compared with the control group, the intervention 
group would have fewer compulsory admissions. 
Secondary hypotheses tested whether, compared with the 
control, the intervention group would have fewer 
psychiatric admissions, shorter psychiatric stays, lower 
perceived coercion, improved therapeutic relationships, 
and improved engagement. We stratiﬁ ed participants by 
centre. The research team (but not participants nor 
clinical staﬀ ) were masked to allocation. A prespeciﬁ ed 
subgroup analysis investigated the use of the MHA for 
black patients since a high rate of MHA use has been 
noted in the black population in England.14
Methods
Study design and participants
We did an individual level, single-blind, intention-to-treat 
randomised trial, which compared the JCP intervention, 
combined with treatment as usual, with a control group 
who received only treatment as usual. We recruited 
participants in three sites across England (Birmingham 
and Solihull Mental Health Foundation Trust; Lancashire 
Care NHS Foundation Trust and Manchester Mental 
Health and Social Care Trust; and South London and 
Maudsley NHS Foundation Trust) between August, 2008, 
and March, 2010, and followed them up 18 months after 
randomisation. Eligibility criteria were: a relapsing 
psychotic illness; aged over 16; at least one psychiatric 
admission in the previous 2 years; and registered on 
Enhanced CPA (ie, the integrated mental health care 
system for those mental health service users with the 
most complex needs). We excluded those who were 
detained under the MHA or were current inpatients, to 
reduce perceived pressure to participate. To enhance the 
generalisability of the sample, we made no further 
exclusions. Translations of materials and interpreters 
were used when needed. The trial received ethical 
approval by the King’s College Hospital Research Ethics 
Committee (07_H0808_174) and is registered with 
Current Controlled Trials ISRCTN11501328.
We recruited from generic and specialist community 
mental health teams in four English Mental Health 
Trusts. In each Trust a list of eligible participants was 
generated and research assistants approached the 
relevant clinical team to arrange a meeting. Patients were 
given a leaﬂ et about the study and were asked to give 
written consent for participation and access to their 
medical records.
Sample size
The sample size of 270 in each group was chosen so that, 
after allowing for 15% loss to follow up and using a 
signiﬁ cance level of 0·05, a reduction by half in primary 
outcome of the overall proportion admitted under the 
MHA could be detected with 90% power (from 30% to 
15%). This sample size would also allow detection of a 
proportionate reduction for a prespeciﬁ ed subgroup of 
interest, black patients, with 80% power (from 40% to 
20%), assuming that the overall sample would yield an 
achieved subsample of 91 per group based on the 
proportions of black patients at the three sites. Eﬀ ect 
sizes for continuous secondary outcomes of around 
0·3, with 90% power would also be detected.
Randomisation and masking
After baseline assessment, we stratiﬁ ed participants by 
site and randomly allocated them to intervention or 
control group using permuted blocks of randomly 
varying block size, with equal allocation to the two 
groups. The allocation sequence was generated by the 
independent clinical trials unit at the study coordinating 
centre. The JCP facilitators at each site were notiﬁ ed by 
an automatic email from the clinical trials unit of 
participants at their Trust who were allocated to the 
intervention or control. Investigators, research assistants 
(who did the follow-up), and trial statisticians were 
masked to allocation. Qualitative data were collected by 
separate qualitative researchers (SF, HL, DR) who were 
not involved in baseline and follow-up assessments, and 
occurred after a participant’s follow-up to ensure research 
assistants were not unmasked. Qualitative researchers 
were not masked because they speciﬁ cally interviewed 
intervention group participants only.
Procedures
To establish whether the JCP was better than standard 
care, we chose treatment as usual under the CPA3 as our 
control condition. The trial therefore compared JCP with 
CPA versus CPA alone.
The JCP intervention is described in detail else where.9–11 
In brief, ﬁ ve senior mental health nurses were employed 
as JCP facilitators to deliver the intervention. In addition 
to treatment as usual, each participant in the inter ven-
tion group was invited to two meetings (preparatory 
and planning), organised by the JCP facilitator. At the 
prepara tory meeting, the facilitator introduced the 
participant and their care coordinator to the principles of 
Joint Crisis Planning and the so-called JCP menu, a list 
of types of content that participants might want to 
include in their JCP. The planning meeting was to be 
attended by the participant, their psychiatrist, the JCP 
facilitator, and the care coordinator. Participants could 
also invite a friend or relative. At this meeting the JCP 
was ﬁ nalised. The presence of the JCP facilitator was 
thought to empower the participant to express and 
discuss their own treatment wishes with clinicians, 
Articles
1636 www.thelancet.com   Vol 381   May 11, 2013
which would in turn facilitate earlier help-seeking and 
self-help strategies, reducing the need for compulsory 
admission. The free expression of partici pants’ wishes 
and subsequent discussion with clinicians moderated by 
the JCP facilitator was thought to be a key diﬀ erence 
between the JCP process and the routine care planning 
undertaken as part of the CPA. After the planning 
meeting the JCP was approved by the participant, and a 
paper copy was disseminated to the participant, psychia-
trist, care coordinator, and anyone else nominated by the 
participant, and was uploaded to the participant’s elec-
tronic patient records. 9 months later the JCP facilitator 
again contacted participants to ask if they wanted to 
update the plan. To ensure ﬁ delity, we provided week-
long training and assessment for the JCP facilitators 
before starting, and weekly supervision with one of the 
developers of the JCP (KS). Fidelity ratings of a randomly 
selected sample of recordings from each facilitator, and 
from the beginning, middle, and end of the intervention 
period, were rated by KS using a standardised form. 
16 items measured the extent to which facilitators 
developed rapport with the participant, remained neutral 
in the negotiations, structured the meetings, addressed 
disagreement (when applicable), encouraged discussion 
between participants and their clinicians, facilitated 
patient choice, and accurately presented the participants’ 
treatment wishes as agreed at the planning meeting. 
Items were scored on a Likert scale ranging from 0 to 2, 
with higher ratings indicating higher ﬁ delity. A ﬁ nal 
ﬁ delity score was generated by summing the items and 
dividing by the number of applicable items to generate a 
percentage. Deviations from the model were addressed 
during supervision. We also rated the quality of each JCP 
using a standardised format. Higher quality JCPs were 
deﬁ ned as those that were written in the ﬁ rst person, 
with unambiguous and non-technical language, and 
without grammatical or spelling errors.
Data were extracted at baseline and at 18 months after 
randomisation. Our primary outcome was admission 
under the MHA. Data for admissions were extracted 
from clinical records, while other outcomes were assessed 
from interviews with participants. Our hypothesis was 
that the primary outcome (number of compulsory admis-
sions) would be signiﬁ cantly lower in the inter vention 
group at follow up. Our secondary outcomes were chosen 
because they covered a range of critical issues identiﬁ ed 
through our initial literature review, exploration of 
stakeholder perspectives, and preparatory research. In 
addition to voluntary admis sions and length of stay, they 
included the therapeutic relationship (self and clinician-
rated Working Alliance Inventory [WAIC and WAIT] 
adapted for use in community settings15), perceived 
coercion (MacArthur Perceived Coercion Scale,16 self-
rated), and engagement (Service Engagement Scale,17 
clinician-rated). Higher scores were worse on all scales. 
Masked research assistants also rated the Global 
Assessment of Functioning (Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition),18 and collected 
service use and demographic information. A subgroup 
analysis speciﬁ cally investigated the use of the MHA for 
black patients. The main hypotheses of our study are 
listed in panel 1.
Statistical methods
All analyses used SPSS version 16 or Stata version 11. 
Bias due to missing follow-up data was assessed by 
comparing baseline characteristics of those with and 
without complete data. Analysis was done under 
intention-to-treat principles. The proportions admitted to 
hospital at follow up were compared between random-
isation groups using χ² tests and logistic regression. 
Days in hospital and under a section of the MHA were 
analysed using t tests and linear regression with robust 
standard errors to account for skewed data. Number of 
admissions (voluntary and under the MHA) were 
analysed using the t test and rank sum non-parametric 
test, and Poisson regression. These analyses were con-
trolled for site, and for variables associated with missing 
outcomes. Continuous out comes were analysed with 
linear regression. These were controlled for baseline 
(pre-intervention) measures, site, and variables asso-
ciated with missing outcomes. As a sensitivity analysis, 
the regressions were repeated including random eﬀ ects 
for mental health teams. The analyses were repeated 
within the black subgroup, prespeciﬁ ed as those specify-
ing their ethnicity as black/black British (Caribbean), 
black/black British (African), black/black British (other), 
mixed (white and black Caribbean), or mixed (white and 
black African).
Qualitative evaluation
Focus groups and semi-structured interviews with 
intervention group participants were done at each site. 
Separate patient and care coordinator focus groups were 
held, followed by combined groups. Individual inter-
views were also done with psychiatrists, care co ordinators, 
and patients. Diﬀ erent qualitative methods were used for 
Panel 1: Hypotheses
The primary hypothesis was that, compared with controls, the 
proportion of participants sectioned under the Mental Health 
Act would be signiﬁ cantly lower for the intervention group.
Secondary hypotheses were that, compared to controls, for 
the intervention group:
• The proportion of participants admitted to a psychiatric 
unit would be signiﬁ cantly lower.
• The length of stay on a psychiatric unit would be 
signiﬁ cantly shorter.
• Self-rated perceived coercion would be lower.
• Self-rated and clinician-rated therapeutic relationships 
would be improved.
• Clinician-rated patient engagement would be improve d.
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pragmatic reasons (eg, almost all psychiatrists preferred 
one-to-one rather than group interviews) and speciﬁ cally 
to use the strength of focus groups in terms of drawing 
out views on sensitive issues where group dynamics 
can add particular value.19 All interviews and focus 
groups were done after the follow-up assessment. 
Inductive thematic analysis, including constant com-
parison methods,20,21 were used to analyse data that 
speciﬁ cally related to explaining the trial out comes. 
Disconﬁ rming evidence was sought throughout. NVIVO 
version 9 was used to help manage the data.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the manuscript. The corresponding author 
had full access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
569 participants from 64 generic and specialist mental 
health teams provided informed consent and were 
randomised (ﬁ gure). Table 1 shows the baseline char-
acteristics of the participants. Stratiﬁ ed randomisation 
ensured roughly equally sized samples from each site in 
each group and there were no substantial diﬀ erences in 
any baseline characteristics. The median length of follow 
up was 557 days (18·5 months, range 3 months [death 
due to unrelated physical causes] to 36 months [diﬃ  -
culties locating participant]). Masking was maintained in 
93% of cases.
Fidelity to the intervention was high, with an average 
rating of 86% across the three sites. The quality of all 
JCPs was assessed with an average rating of 93%. 48% of 
JCP meetings took place during a routine CPA meeting, 
and 67% were attended by the full direct-care clinical 
team (ie, psychiatrist and care coordinator). All JCPs were 
made with two meetings (where there were signiﬁ cant 
delays in the planning meeting, a small proportion [1·8%] 
of patients had two preliminary meetings).
Data for the primary outcome (admission to hospital 
under a compulsory section of the MHA) were missing 
(ie, refused access) for 22 of the 569 participants (4%). 
Those with missing data for the primary outcome were 
similar to those with such data, except that the former 
had signiﬁ cantly worse self-rated therapeutic relationship 
(WAIC) scores (18·6 vs 15·8, p=0·043) and were more 
likely to be in the intervention group (n=18, 6%) than in 
the control group (n=4, 1%).
The degree of missing data varied across secondary 
outcome measures: 20% of participants were missing 
perceived coercion score, 24% were missing engagement 
with care scores, and 22% were missing WAIC and 
WAIT scores at follow up. Participants missing secondary 
outcomes at follow-up were more likely to come from 
the intervention group for all outcomes: 56% perceived 
coercion, 60% service engage ment, 64% WAIC, and 63% 
of those missing WAIT. Diagnosis was also associated 
with missing data in all of the secondary outcomes. Site 
was associated with missing data for perceived coercion, 
service engagement, and WAIC. Missing service engage-
ment data was also associated with a higher Global 
Assess ment of Functioning score, missing WAIC 
associated with number of previous admissions, and 
missing WAIT associated with marital status and Global 
Assessment of Functioning score.
Data for demographic, therapeutic relationship, and 
patient engagement were obtained from the case 
managers or other named clinicians (care coordinators); 
however, 35 (6%) of 569 of the care coordinators did not 
complete these at baseline. Care coordinators were 65% 
women, 71% were white, 62% were nurses, and they had 
an average age of 42 years.
Admissions data at follow-up are shown in table 2. For 
the primary outcome (compulsory admission), 56 (20%) 
in the control group and 49 (18%) in the JCP group 
were admitted compulsorily, with a mean duration of 
20·6 (SD 73·4) days in the control group and 
22·3 (72·0) days in the JCP group. For any admission 
(compulsory or voluntary), the mean durations were 
26·4 (76·2) days in the control group and 29·5 (75·7) days 
in the JCP group. There were a total of 158 admissions 
Figure: Trial proﬁ le 
*18 and †4 missing primary outcome data.
5703 participants assessed 
for eligibility
5134 excluded
 4282 did not meet 
  inclusion criteria
 517 refused to 
  participate
 335 uncontactable or 
  more info required
285 allocated to JCP intervention
 221 received intervention
 64 did not receive 
  intervention
 41 refused intervention
 8 discharged
 7 too unwell
 6 did not attend
 2 other
284 allocated to control
 284 received intervention
 0 did not receive 
  intervention
19 lost to follow-up
 13 refused
 5 deceased
 1 uncontactable
46 lost to follow-up
 34 refused
 8 deceased
 4 uncontactable
284 analysed
 0 excluded from analysis†
285 analysed
 0 excluded from analysis*
569 randomised
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under either compulsory or voluntary status: 81 (29%) in 
the control group and 77 (29%) in the JCP group. Medians 
for these admission data are shown in table 2. In bivariate 
analyses, no signiﬁ cant diﬀ erences were noted between 
the randomisation groups in terms of propor tion of 
admissions, number, or duration of admissions over the 
follow-up period.
Regression analyses adjusting treatment eﬀ ect esti-
mates for site (which was a design factor) and the WAIC, 
(which was associated with having missing data) showed 
no signiﬁ cant treatment eﬀ ect for the primary outcome 
or for any of the other admissions outcomes. When 
random eﬀ ects for the 64 mental health teams were 
included, very similar results were obtained.
The three continuous secondary outcomes are sum-
mar ised in table 3. There was some evidence for an 
improvement in self-rated therapeutic relationship 
(WAIC) in the intervention group (17·3 [7·6] vs 16·0 [7·1], 
unadjusted diﬀ erence −1·29 [95% CI −2·67 to 0·09, 
p=0·066]), when controlling for factors associated with 
the trial design and loss to follow-up (baseline value, site, 
number of previous admissions, diagnosis, and baseline 
WAIC [−1·28 95% CI −2·56 to −0·01, p=0·049]). There 
were no signiﬁ cant diﬀ erences between groups in the 
other secondary outcomes. Regression analyses with 
adjustment made negligible diﬀ erence to these ﬁ ndings 
(appendix).
147 black/black British participants were recruited and 
randomly assigned, 75 to the control group and 72 to the 
JCP group. We obtained admissions data at follow up for 
138 (94%) of the participants. A further nine did not 
complete the follow up interview, giving 129 (88%) with 
follow up information. No baseline characteristics were 
found to be signiﬁ cantly associated with missing 
admissions data in this subgroup, although as a 
sensitivity analysis and for consistency with the full 
sample analysis we adjusted for baseline WAIC.
No signiﬁ cant diﬀ erence was seen within the black 
subgroup for any admission outcomes between those 
randomised to the JCP group compared with controls. 
13 (20%) participants assigned to the JCP group had a 
compulsory admission in the follow up period com-
pared with 23 (32%) in the control group (adjusted 
odds ratio 0·56, 0·25–1·25, p=0·16). Admission out-
comes are shown in table 4. There were a total of 
45 admissions under compulsory or voluntary status: 
18 (27%) in the JCP group and 27 (38%) in the control 
group (adjusted odds ratio=0·67, 0·32–1·39, p=0·28). 
There was no signiﬁ cant treatment eﬀ ect of JCP over 
controls found in any of the secondary measures 
within the subgroup (appendix).
12 focus groups were done: ﬁ ve patient groups, ﬁ ve care 
coordinator groups, and two combined groups. Respon-
dent validation occurred during combined focus groups 
with ten participants who had participated previously. 
Overall, 58 people attended a focus group: 35 patients, 
22 care coordinators, and one psychiatrist (at a combined 
group). 37 individual interviews were also done with 
16 psychiatrists, six care coordinators, and 15 patients. 52% 
of patients were women, mean age 39·2 years (SD 9·6), 
and 64% were white, 32% were black, and 4% were Asian. 
58% of care coordinators were women, mean age 
43·8 years (SD 8), and 75% were community psychiatric 
nurses. 20% of psychiatrists were women, with an average 
of 6·5 years (range 3–11 years) as a consultant. 85 people 
were included in the qualitative study.
Our qualitative data provide support for the improve-
ment in patients’ views of the therapeutic relationships 
and suggest that JCPs could make a positive diﬀ erence to 
both patients and clinicians. For example, patients felt 
respected and more understood by clinicians, particularly 
in relation to their wishes regarding future treatment. 
Some clinicians seemed to gain a wider understanding of 
Total (n=569) Control (n=284) JCP (n=285)
Number of patients by site
Birmingham 192 (34%) 96 (34%) 96 (34%)
London 192 (34%) 96 (34%) 96 (34%)
Manchester or Lancashire 185 (33%) 92 (33%) 93 (33%)
Sex
Male 285 (50%) 146 (51%) 139 (49%)
Age
Mean (SD) 39·8 (11.9) 39·6 (12·1) 40·0 (11·8)
Housing status
Live alone 251 (44%) 122 (43%) 129 (45%)
Ethnic origin
White 353 (62%) 179 (63%) 174 (61%)
Asian or Asian British 56 (10%) 23 (18%) 33 (12%)
Black or black British 126 (22%) 65 (23%) 61 (21%)
Mixed 28 (5%) 13 (5%) 15 (5%)
Other 5 (1%) 3 (1%) 2 (1%)
Education
No formal qualiﬁ cation 153 (27%) 67 (24%) 86 (30%)
School 291 (51%) 158 (56%) 133 (47%)
Vocational 52 (9%) 22 (8%) 30 (11%)
Higher 71 (12%) 37 (13%) 34 (12%)
Diagnosis
Schizophrenia spectrum disorder 422 (74%) 212 (75%) 210 (74%)
Aﬀ ective disorders 147 (26%) 72 (25%) 75 (26%)
Follow-up
Mean length of follow-up in days (SD) 570 (73) 565 (59) 576 (86)
Number of admissions in previous 2 years
1 391 (69%) 205 (72%) 186 (65%)
2 120 (21%) 51 (18%) 69 (24%)
≥3 58 (10%) 28 (10%) 30 (11%)
Mean (SD) 1·49 (0·99) 1·44 (0·88) 1·54 (0·99)
Total duration of admissions in previous 2 years
Mean (SD) 102 (118) 105 (126) 100 (112)
Median (IQR) 59 (31–129) 55 (31–123) 66 (30–132)
Data are n (%) unless otherwise stated. JCP=Joint Crisis Plan.
Table 1: Baseline characteristics
See Online for appendix
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patients’ views of care and presentation in a crisis. These 
beneﬁ ts appeared to occur when the JCP meeting acted 
as a vehicle for clinicians to demonstrate respect for 
patients’ experiences and views on treatment, for 
instance through active listening. However, a more 
common scenario was poor engagement with the process 
of developing the JCP and implementation of the JCP in 
practice. Many patients, for example, could not remember 
the JCP planning meeting as anything distinct from a 
routine CPA meeting. There were three particular 
barriers to implementation. First, many clinicians 
believed they were already carrying out joint care plan-
ning and that the JCP added very little. However, clinician 
descriptions of joint planning in CPA meetings suggest 
that both the meeting and the plans generated were 
clinician led rather than patient led. For the JCP meeting 
to be beneﬁ cial, it needed to be suﬃ  ciently demarcated 
from a CPA meeting both in terms of time and ethos 
(which was not achieved since 48% of JCP meetings took 
place in association with a routine CPA meeting). There 
was also considerable ambivalence about routine care 
planning generally, as many clinicians saw it as a 
bureaucratic exercise with limited clinical beneﬁ t. 
Second, most clinicians failed to recognise that 
implementing the JCP required a change in the usual 
clinician-patient relationship on their part, beginning 
with active discussion of treatment options and sup-
porting patient choice both in the meeting and in 
implementation. Third, implementation in practice 
required commitment by all participants within a 
complex system; however, many patients complained 
that the agreements in the JCPs were not honoured in 
practice and only ﬁ ve of the 28 care coordinators reported 
referring to or using the JCP during the follow-up period. 
Experiences were common to patients from diﬀ erent 
ethnic groups (see appendix for participant quotes).
Discussion
We found no diﬀ erences between the intervention and 
control groups for the primary outcome (namely com-
pulsory admissions), either for the total sample or black 
subgroup. We found a modest improvement in thera-
peutic relationship in the intervention group, but no 
other diﬀ erences on other secondary outcome measures. 
Qualitative analysis found that although some patients 
had a positive experience of JCP, many described how 
clinical services struggled to put it into practice.
Why should these ﬁ ndings be so markedly diﬀ erent 
from those of two previous JCP studies?9,11 First, the 
intervention might have been delivered with lower ﬁ delity 
to the model, but this is unlikely because the mean ﬁ delity 
score was high in this trial (although we did not include in 
the ﬁ delity scale a rating of whether the JCP meeting was 
done at the same time as the routine clinical review 
meeting). Second, crisis planning in the control group 
might have improved considerably since our ﬁ rst study, 
although this also seems unlikely since an assessment of 
routine crisis plans for the trial participants indicated that 
they were of poor quality (eg, only 27% contained one or 
more items of information speciﬁ c to the individual). 
Third, clinician engagement could have been poor both 
at crisis planning meetings and subsequently. This 
Control group JCP group Diﬀ erence
N Mean (SD) N Mean (SD) Mean (95% CI) p value
Perceived coercion 245 2·33 (1·68) 213 2·10 (1·76) 0·23 (–0·08 to 0·55) 0·16
Service engagement scale 228 9·74 (7·26) 202 10·05 (7·15) 0·31 (–1·06 to 1·68) 0·65
WAIC 240 17·3 (7·6) 106 16·0 (7·1) –1·29 (–2·67 to 0·09) 0·07
WAIT 238 17·5 (5·1) 208 17·1 (5·2) –0·44 (–1·40 to 0·53) 0·37
JCP=Joint Crisis Plan. WAIC=Working Alliance Inventory-client. WAIT=Working Alliance Inventory-therapist.
Table 3: Secondary outcome measures by randomisation group
Control 
group 
(n=72)
JCP group 
(n=66)
Odds ratio (95% CI) p value
At least one period of compulsory 
admission
23 (32%) 13 (20%) 0·52 (0·24 to 1·14) 0·10
At least one admission (compulsory or 
voluntary)
27 (38%) 18 (27%) 0·63 (0·30 to 1·29) 0·20
Duration of compulsory admissions (days)
Mean (SD) 48·1 (119·8) 31·8 (95·4) –16·32 (–53·0 to 20·3) 0·38
Median (range) 0 (0–600) 0 (0–507) ·· 0·08
Duration of admissions (days)
Mean (SD) 54·7 (121·3) 36·3 (97·8) –18·36 (–55·66 to 18·94) 0·33
Median (range) 0 (0–600) 0 (0–507) ·· 0·17
Number of admissions
Mean (SD) 0·64 (1·15) 0·58 (1·24) 0·90 (0·59 to 1·38) 0·64
Median (range) 0 (0–6) 0 (0–7) ·· 0·31
JCP=Joint Crisis Plan.
Table 4: Summary of admission outcomes at follow-up by randomisation group for black subgroup
Control 
group 
(n=280)
JCP group 
(n=267)
Odds ratio (95% CI) p 
value
At least one period of compulsory admission 56 (20%) 49 (18%) 0·90 (0·59 to 1·38) 0·63
At least one admission (compulsory or 
voluntary)
81 (29%) 77 (29%) 1·00 (0·69 to 1·44) 0·98
Duration of compulsory admissions (days)*
Mean (SD) 20·6 (73·4) 22·3 (72·0) 2·21 (–10·01 to 14·43)† 0·72
Median (range) 0 (0–600) 0 (0–507) ·· 0·53
Duration of admissions (days)*
Mean (SD) 26·4 (76·2) 29·5 (75·7) 3·04 (–9·72 to 15·81) 0·64
Median (range) 0 (0–600) 0 (0–507) ·· 0·92
Number of admissions*
Mean (SD) 0·48 (0·92) 0·51 (1·01) 1·06 (0·84 to 1·35)‡ 0·61
Median (range) 0 (0–6) 0 (0–7) ·· 0·96
JCP=Joint Crisis Plan. *Summary data for entire sample including those who were not admitted during the follow-up 
period. †Diﬀ erence (95% CI). ‡Rate ratio (95% CI).
Table 2: Summary of admission outcomes at follow-up
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explanation is supported by our ﬁ nding that in 48% of 
cases JCPs were not formulated at speciﬁ c meetings, but 
were discussed at the same time as CPA reviews (this only 
took place where clinical staﬀ  did not make themselves 
available to discuss the JCP outside of the usual clinical 
review meeting). In a third of cases, the full clinical team 
was not present. Our qualitative work suggests that many 
patients could not remember the JCP planning meeting 
as distinct from a routine CPA meeting. Further, many 
patients com plained that the content was not followed 
during a subsequent crisis. The clinicians’ readiness to 
engage in the approach could be a crucial component of 
success (panel 2). Our previous eﬃ  cacy trial involved 
clinicians who expressed an interest in the intervention, 
whereas this eﬀ ectiveness study involved an arguably 
more generalisable sample of clinicians, resulting in more 
variable clinician buy-in to the JCP process,24 and indeed 
participating teams and clinicians were assertively 
recruited and followed up within sites, with few outright 
refusals. In eﬀ ect, therefore, the trial compared JCP plus 
CPA against CPA alone. Our results indicate that the 
eﬀ ects of the two processes were in rather opposite 
directions. The CPA was seen by patients as a routine 
process that did not include their preferences in any 
meaningful way, whereas staﬀ  tended to see the CPA as 
an imposed operational requirement. Patients tended to 
see the JCP as a highly acceptable process that did respect 
their point of view, while many staﬀ  saw the JCP as an 
optional extra oﬀ ering little extra beneﬁ t. In terms of the 
actual use of the JCPs, the results suggest a lack of buy-in 
by staﬀ  into the JCP process. In this context, the JCP 
ﬁ delity measure did not suﬃ  ciently sensitively identify 
this lack of staﬀ  engagement.
The UK Department of Health’s Operating Framework 
for the NHS25 for 2012–13 states that it puts “patients at 
the centre of decision making”; our results suggest that 
the current CPA framework fails to facilitate this 
aspiration. The CPA is often seen as a bureaucratic 
structure that constrains both clinicians and patients 
within a power hierarchy. Some clinicians feel that rigid 
adherence to the CPA is a form of risk management 
against blame for any future adverse events.26 The JCP 
challenges the ethos of the CPA because it calls for the 
clinician to share or cede signiﬁ cant power to the patient. 
Where the JCP meeting worked well, patients reported 
feeling respected, and clinicians talked about how the 
patient “came alive” as an individual, indicating a more 
personalised approach to care.27
Limitations of the study include the fact that at least some 
of the community mental health teams were not adequately 
prepared to deliver the JCP intervention as separate from 
the CPA, and had little sense of ownership of it. In the 
emerging ﬁ eld of implementation science, the factors 
needed to put a new intervention (one eﬃ  cacious in early 
trials) into routine, eﬀ ective clinical practice (ie, to opti-
mise implementability) are becoming more clearly 
understood.28–30 For example, the few studies of imple-
menting mental health clinical guide lines within mental 
health care have shown only modest results in terms of 
patient beneﬁ t.29–31 Furthermore, the JCP is a complex 
intervention and within this trial we did not include an 
extended formative stage where we could discuss the 
attitudes of clinicians to adoption in routine clinical use, 
and in retrospect this could have been a crucial limitation 
of the study.32–34 The JCP intervention was introduced to 
clinical teams without speciﬁ c attention to the local staﬀ  or 
organisational context or readiness for this process,35 an 
important prerequisite for successful adoption of a new 
inter vention. Our ﬁ delity measure was also clearly not 
suﬃ  ciently sensitive and therefore requires further 
development. These considerations should be examined in 
subsequent replication studies. Furthermore, the economic 
evaluation (unpublished) highlights diﬀ erential levels of 
cost-eﬀ ectiveness by ethnic group, thus support ing further 
exploration of JCPs in particular for black ethnic groups.
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